Schroder Investment Management Group’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-288,726	Closed	-$1.42M	–	1279
2024 Q1	$1.42M	Hold	288,726	–	–	﹤0.01%	973
2023 Q4	$2.54M	Buy	+288,726	New	+$2.54M	﹤0.01%	874
2014 Q3	–	Sell	-50,000	Closed	-$1.7M	–	1499
2014 Q2	$1.7M	Buy	+50,000	New	+$1.7M	﹤0.01%	898